MAR 06, 2018 10:00 PM PST

Increasing Endogenous Cannabinoid Levels May Reduce Neuropathic Orofacial Pain

WRITTEN BY: Mauri Brueggeman

Neurotransmitter systems in the body have incredible functionality and versatility.  One such system is the Endocannabinoid System (ES).  Studies have begun examining the complex interaction of this system in the body and within numerous physiological processes. Recent research has shown the usefulness of cannabis compounds, specifically cannabinoids, in the treatment of neuropathic pain through ES complex signalling mechanisms.  Many have focused their attention solely on phytocannabinoids found in the cannabis plant or endocannabinoids found in the human body.  Still others have explored the pathophysiological process to better understand neuropathic pain.

The process of feeling or sensing pain involves the endocannabinoid system and researchers have found cannabis and phytocannabinoids can reduce neuropathic pain symptoms.  Some groups have chosen to evaluate options for reducing pain in specific types of neuropathies.  One area of active research is in neuropathic orofacial pain (NOP). 

There are a multitude of causes for NOP and the underlying physiological process of why that pain occurs is mostly unknown so identifying therapeutic options is challenging.  Researchers in Europe began looking that this years ago but a new article in Journal of Oral Science’s March 2018 publication provides new insights into the possibilities of pain management for orofacial pain.

The group began examining how endocannabinoids (produced in the body) affect pain receptors and designed an animal study to manipulate endocannabinoids in vivo and evaluate their perceived effects on NOP.  Kamimura, et al., (J Oral Sci) postulated that the endocannabinoid 2-arachydonoylglycerol (2-AG) present in the brain could reduce the pain signals generated by orofacial nerve injury or damage.  2-AG is degraded by enzymes in vivo causing pain signals to chronically persist.  The researchers introduced an inhibition factor, JZL184, which prevents the enzymatic action of monoacylglycerol (MAGL).  MAGL breaks down 2-AG in vivo.

Upon completion of this study, Kamimura, et al. found that by restricting degradation of 2-AG, therefore leaving increased amounts of endogenous 2-AG in the brain, orofacial pain was attenuated.  This mechanism shows promise for future therapeutic treatment options for NOP.  Additional challenges are the differences between animal studies and translation to human trials; however, because the compounds used in the study are endogenous normally, perhaps converting the design for clinical trials may not be quite as challenging. 

 

 

 

Sources: Journal of Oral SciencePain, International Journal of Biochemistry and Cell Biology,

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
NOV 19, 2019
Cannabis Sciences
NOV 19, 2019
Cannabis Can't Simply Replace Opioids for Pain Management
According to the research, cannabis is not effective when it comes to treating individuals struggling with opioid use disorder. While some may have conside...
JAN 03, 2020
Cannabis Sciences
JAN 03, 2020
Potent Pot May Boost Risk of First Cannabis Disorder Sign
Recreational cannabis is legal in 10 states and Washington, DC, but regulations regarding potency do not exist. The results of a new study may prompt state...
JAN 09, 2020
Cannabis Sciences
JAN 09, 2020
Virginia Governor Pushes Cannabis Decriminalization
Will the Old Dominion accept marijuana decriminalization? Democrats took the majority in Virginia’s state House and Senate in 2019, opening the door ...
JAN 10, 2020
Health & Medicine
JAN 10, 2020
Are Edibles the Safest Option for Marijuana Users?
Cannabis edibles are growing in popularity, while cannabis products become more widely accepted across the country and beyond. However, it looks like scien...
JAN 22, 2020
Cannabis Sciences
JAN 22, 2020
People Struggling with Pain Also Struggle with Cannabis Use Disorder
The hype in the media that surrounds cannabis and health benefits supposedly associated with its use may be detrimental to individuals with certain conditi...
JAN 29, 2020
Cannabis Sciences
JAN 29, 2020
In Sicily, Medical Cannabis Is Now Free
The Sicilian government will now foot the bill for many patients using medical cannabis. Sicily’s top health administrator, Ruggero Razza, announced...
Loading Comments...